Risk Stratification of Men with Gleason Score 7 to 10 Tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database

Urology

Volumn 70, Issue 2, 2007, Pages 277-282

  Kang, David E ^a   Fitzsimons, Nicholas J ^a   Presti Jr , Joseph C ^b,c   Kane, Christopher J ^d,e   Terris, Martha K ^f,g   Aronson, William J ^h,i   Amling, Christopher L ^j   Freedland, Stephen J ^a,k,l  

^a DUKE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Alabama   (United States)

^k DURHAM VA MEDICAL CENTER   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; DATA BASE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TUMOR BIOPSY;

BIOPSY; DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 34548461739     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.059     Document Type: Article

References (23)

1. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58 (2001) 843-848
2. Diblasio C.J., and Kattan M.W. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62 suppl 1 (2003) 9-18
3. D'Amico A.V., Whittington R., Malkowicz B.M., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
4. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 277 (1997) 1445-1451
5. Makarov D.V., Sanderson H., Partin A.W., et al. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?. J Urol 167 (2002) 2440-2442
6. Rasiah K.K., Stricker P.D., Haynes A.M., et al. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98 (2003) 2560-2565
7. Gonzalgo M.L., Bastian P.J., Mangold L.A., et al. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. Urology 67 (2006) 115-119
8. Freedland S.J., Amling C.L., Dorey F., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670-674
9. Lerner S.E., Blute M.L., Bergstralh E.J., et al. Analysis of risk factors of progression in patients with pathologically confined prostate cancer after radical retropubic prostatectomy. J Urol 156 (1996) 137-143
10. Tollefson M.K., Leibovich B.C., Slezak J.M., et al. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol 175 (2006) 547-551
11. Han M., Snow P.B., Epstein J.I., et al. A neural network predicts progression for men with Gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology 56 (2000) 994-999
12. Sakr W.A., Tefilli M.V., Grignon D.J., et al. Gleason score 7 prostate cancer: a heterogeneous entity?. Correlation with pathologic parameters and disease-free survival. Urology 56 (2000) 730-734
13. Chan T.Y., Partin A.W., Walsh P.C., et al. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology 56 (2000) 823-827
14. Stamey T.A., Yemoto C.M., McNeal J.E., et al. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163 (2000) 1155-1160
15. Epstein J.I., Pound C.R., Partin A.W., et al. Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol 160 (1998) 97-100
16. Freedland S.J., Csathy G.S., Dorey F., et al. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 167 (2002) 516-520
17. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 281 (1999) 1395-1400
18. D'Amico A.V., Cote K., Loffredo M., et al. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 169 (2003) 1320-1324
19. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715-717
20. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
21. Albertsen P.C., Hanley J.A., Barrows G.H., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248-1253
22. Carlson G.D., Calvanese C.B., Kahane H., et al. Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. Urology 51 (1998) 525-529
23. Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433-439